05.09.2022 | Tracker

Respiratory tracker: Climate crisis = Health crisis, HCPs share their opinions at ERS 2022

By Mark Sullivan

Between 21 August and 20 September CREATION Pinpoint® tracked the online conversations of UK HCPs discussing respiratory diseases. Within this month-long date-range there were 2,307 posts about conditions ranging from asthma to COVID-19 from 1,075 HCPs in the UK. This was an average of 76.9 mentions per day, marginally less than the previous 3 months daily level of conversation. Within this conversation the most frequent poster was Pharmacist Garry McDonald, with 47 posts. 

Graph showing UK HCP mentions on Twitter in September

This month UK HCPs were most active on 06 September, posting about respiratory diseases 193 times. This corresponded to the ‘European Respiratory Society (ERS) International Congress’ which took place in Barcelona from 4-6 September. As can be seen in the chart above, UK HCPs discussed respiratory diseases far more frequently around this event. This is a common theme of congress and one of the many reasons why CREATION offers Congress Tracking to understand HCPs’ opinions, needs, and concerns about products and data during this time. An interesting thread which garnered attention from both HCPs and non-HCPs was from Pulmonologist Laura Jane Smith, who shared her thoughts on the health and climate impact of travelling to in-person congresses.

Whilst the ERS congress generated the most conversation for UK HCPs, it was a post from Professor of Intensive Care Medicine, Charlotte Summers, which was shared by more UK HCPs than any other respiratory disease post this month. 31 UK HCPs shared the post which highlighted the dangers of misinformation and why context is so important to the statistics we see every day. Sam Porter, a Consultant Perinatal Psychiatrist, used the same logic to satirise misrepresentation of statistics. Charlotte Summers discussed the changing landscape of respiratory care with a patient, as “practice always evolves as we learn”.



A world issue which has not been ignored by HCPs is that of the energy crisis, in fact many HCPs have shed light on the damaging impact to healthcare that an energy crisis would bring. GP Amir Khan spoke on Good Morning Britain about how children from colder homes are more likely to suffer mental health and respiratory problems. This was also raised at the ERS congress, where Nick Hopkinson shared a recent article surrounding socioeconomic factors and their impact on health and wellbeing, and concluded  “Living in a cold, damp home and poverty are associated with more frequent acute exacerbations of COPD”


Each month, we track the HCP conversation relating to respiratory disease.

You can keep up to date with this and other pharmaceutical tracking updates, including COVID-19 developments, within the Tracking section of CREATION Knowledge, or sign up to receive our monthly eJournal with all of our latest HCP insights. 

If you would like to dig deeper into what we have seen this month then please do get in touch.


  • This article analysed the Twitter conversations of HCPs in the UK discussing respiratory disease and related terms between 21 Aug and 20 September 2022 using CREATION Pinpoint®.
  • Between 21 Aug and 20 September 2022, there were 2,307 UK HCP mentions of respiratory disease and related terms, from 1,075 unique UK HCP authors.

View the latest Respiratory tracker here


View all articles >

Meet the Author

Mark Sullivan

Mark uses his passion for data analysis to find actionable insights to inform pharma teams' strategic decisions.

Mark is an avid sports fan whether watching or playing. He enjoys spending time with his family and friends and watching films.

Suggested next

30.07.2020 | Article

Primed for digital transformation in 2020: Learnings from HCP online engagement with Top 50 Pharma

Discover what healthcare professionals (HCPs) think about Top 50 pharmaceutical companies

By Mary Kangley

06.06.2022 | Article

Product Launch Tracker: HCPs excited by approvals for Eli Lilly, Novartis, Sanofi and Regeneron

Over the last month, HCPs discussed product approvals for the treatment of a variety...

By Paul Cranston and Tomi Shobande

View all articles >